Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Deferred Taxes (2016 - 2018)

Niagen Bioscience (NAGE) has disclosed Deferred Taxes for 6 consecutive years, with -$16000.0 as the latest value for Q4 2018.

  • Quarterly Deferred Taxes fell 100.0% to -$16000.0 in Q4 2018 from the year-ago period, while the trailing twelve-month figure was -$16000.0 through Sep 2019, down 260.0% year-over-year, with the annual reading at $2000.0 for FY2018, 98.89% down from the prior year.
  • Deferred Taxes for Q4 2018 was -$16000.0 at Niagen Bioscience, down from -$8000.0 in the prior quarter.
  • The five-year high for Deferred Taxes was $321037.0 in Q4 2016, with the low at -$50000.0 in Q1 2018.
  • Average Deferred Taxes over 3 years is $50227.5, with a median of -$8000.0 recorded in 2017.
  • The sharpest move saw Deferred Taxes surged 1081.37% in 2016, then tumbled 225.0% in 2018.
  • Over 3 years, Deferred Taxes stood at $321037.0 in 2016, then crashed by 102.49% to -$8000.0 in 2017, then crashed by 100.0% to -$16000.0 in 2018.
  • According to Business Quant data, Deferred Taxes over the past three periods came in at -$16000.0, -$8000.0, and $76000.0 for Q4 2018, Q3 2018, and Q2 2018 respectively.